lidoflazine has been researched along with verapamil in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (80.65) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 1 (3.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, RJ; Johnson, CP; Proakis, AG; Shanklin, JR | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Sen, S; Sinha, N | 1 |
| Arrigo, F; Bramanti, B; Coglitore, S; Consolo, F; Giannetto, M; Melluso, C; Virga, T | 1 |
| De'Thomatis, M; Falciola, N; Gallesio, R | 1 |
| Van Nueten, JM; Wellens, D | 1 |
| Borgers, M; Liu, GS; Ravens, U; Vandeplassche, G | 1 |
| Fabrègues, E; John, GW; Kamal, M; Massingham, R | 1 |
| Borgers, M; De Clerck, F; Vandewiele, R; Ver Donck, L; Verellen, G | 1 |
| Boddeke, HW; Heynis, JB; van Zwieten, PA; Wilffert, B | 1 |
| Beckeringh, JJ; Hugtenburg, JG; Mathy, MJ; van Zwieten, PA | 1 |
| Gudenzi, M; Mustafa, SJ; Nakagawa, Y | 1 |
| Somberg, JC | 1 |
| Borgers, M; Donck, LV; Pauwels, PJ; Vandeplassche, G | 1 |
| Chappell, SP; Henderson, AH; Lewis, MJ | 2 |
| DeLong, RE; Phillis, JW; Towner, JK | 1 |
| Briscoe, MG; Smith, HJ | 1 |
| Barry, WH; Horowitz, JD; Smith, TW | 1 |
| Hashimoto, K; Kimura, T; Kubota, K; Oguro, K | 1 |
| Hashimoto, K; Oguro, K | 1 |
| Collignon, P; Kulbertus, H | 1 |
| Messini, M | 1 |
| Fossati, C; Guistiniani, S | 1 |
| Lewis, JG | 1 |
| Feely, J; Maclean, D | 1 |
| Dorsey, LM; Guyton, RA; Hatcher, CR; Kates, RA | 1 |
| Krause, GS; White, BC; Wilson, RF; Winegar, CD | 1 |
| McIntyre, KM; Parisi, AF; Sasahara, AA; Strauss, WE | 1 |
| Van Nueten, JM; Vanhoutte, PM | 1 |
| Flaim, SF; Zelis, R | 1 |
3 review(s) available for lidoflazine and verapamil
| Article | Year |
|---|---|
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidoflazine; Oxyfedrine; Perhexiline; Practolol; Prenylamine; Verapamil | 1978 |
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendiline; Gastrointestinal Diseases; Humans; Lidoflazine; Nervous System Diseases; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1984 |
Adverse reactions to calcium antagonists.
Topics: Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Kinetics; Lidoflazine; Nifedipine; Perhexiline; Prenylamine; Risk; Verapamil | 1983 |
1 trial(s) available for lidoflazine and verapamil
| Article | Year |
|---|---|
Considerations in evaluating new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Drug Evaluation; Humans; Lidoflazine; Nifedipine; Research Design; Verapamil | 1982 |
27 other study(ies) available for lidoflazine and verapamil
| Article | Year |
|---|---|
Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
Topics: Animals; Antihypertensive Agents; Aorta; Calcium; Calcium Channel Blockers; Hypertension; Male; Molecular Structure; Muscle Contraction; Piperidines; Rabbits; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1991 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardiography; Heart; Heparin; Humans; Lidoflazine; Male; Nitrates; Pindolol; Verapamil | 1977 |
Tissue specificity of calcium-antagonistic properties of lidoflazine.
Topics: Animals; Calcium; Cats; In Vitro Techniques; Lidoflazine; Muscle Contraction; Myocardial Contraction; Organ Specificity; Piperazines; Rats; Verapamil | 1979 |
Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+.
Topics: Animals; Calcium; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Lidoflazine; Piperazines; Rats; Tissue Distribution; Verapamil | 1992 |
Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists.
Topics: Animals; Bepridil; Caffeine; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Flunarizine; Kinetics; Lidoflazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Renal Artery; Verapamil | 1991 |
Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
Topics: Animals; Benzothiazoles; Calcium Channel Blockers; Cell Separation; Cinnarizine; Diltiazem; Flunarizine; Lidoflazine; Lipid Peroxidation; Malondialdehyde; Myocardium; Nicardipine; Oxygen; Piperidines; Rats; Thiazoles; Verapamil | 1990 |
Investigation of the mechanism of negative inotropic activity of some calcium antagonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Arrhythmia Agents; Bepridil; Calcimycin; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Female; Flunarizine; Guinea Pigs; In Vitro Techniques; Lidoflazine; Male; Myocardial Contraction; Pyrrolidines; Verapamil | 1988 |
The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Diltiazem; Gallic Acid; Heart Ventricles; Lidoflazine; Male; Monensin; Myocardial Contraction; Nifedipine; Papillary Muscles; Rats; Rats, Inbred Strains; Ryanodine; Stimulation, Chemical; Verapamil | 1989 |
Calcium entry blocking activity of adenosine potentiating compounds in guinea pig taenia coli.
Topics: Adenosine; Animals; Calcium Channel Blockers; Colon; Dilazep; Diltiazem; Dipyridamole; Drug Synergism; Guinea Pigs; In Vitro Techniques; Lidoflazine; Male; Muscle, Smooth; Nifedipine; Potassium; Vasodilator Agents; Verapamil | 1986 |
Calcium channel blockers that prolong the QT interval.
Topics: Animals; Arrhythmias, Cardiac; Bepridil; Calcium Channel Blockers; Dogs; Electrocardiography; Heart Atria; Heart Ventricles; Humans; Lidoflazine; Pyrrolidines; Quinidine; Systole; Verapamil | 1985 |
Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
Topics: Animals; Calcium; Calcium Channel Blockers; Cinnarizine; Diltiazem; Flunarizine; Heart; Lidoflazine; Male; Myocardial Contraction; Myocardium; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Time Factors; Verapamil; Veratrine | 1986 |
Myocardial reoxygenation damage. Can it be circumvented?
Topics: Animals; Calcium; Cats; Coronary Circulation; Diltiazem; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Lidoflazine; Magnesium; Manganese; Myocardial Contraction; Oxygen Consumption; Papillary Muscles; Rabbits; Verapamil | 1985 |
Myocardial reoxygenation damage: can it be circumvented?
Topics: Animals; Calcium; Cats; Diltiazem; Heart; Hypoxia; In Vitro Techniques; Lidoflazine; Myocardial Contraction; Myocardium; Ouabain; Oxygen; Papillary Muscles; Perfusion; Rabbits; Stimulation, Chemical; Verapamil | 1985 |
The effects of lidoflazine and flunarizine on cerebral reactive hyperemia.
Topics: Animals; Blood Gas Analysis; Cerebrovascular Circulation; Cinnarizine; Extracorporeal Circulation; Flunarizine; Hyperemia; Hypoxia; Lidoflazine; Male; Piperazines; Rats; Rats, Inbred Strains; Verapamil | 1985 |
The relative sensitization by acidosis of five calcium blockers in cat papillary muscles.
Topics: Acidosis; Animals; Calcium Channel Blockers; Cats; Diltiazem; In Vitro Techniques; Lidoflazine; Myocardial Contraction; Nifedipine; Papillary Muscles; Perhexiline; Verapamil | 1985 |
Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Chick Embryo; Gallopamil; Half-Life; Lidoflazine; Myocardial Contraction; Myocardium; Nifedipine; Perhexiline; Time Factors; Verapamil | 1985 |
Effects of various coronary vasodilators on myocardial oxygen consumption.
Topics: Animals; Benzopyrans; Butyrates; Coronary Circulation; Coumarins; Dicarboxylic Acids; Diethylamines; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Glycolates; Heart; Heart Rate; Isoproterenol; Khellin; Lidoflazine; Male; Myocardium; Nitrobenzenes; Nitroglycerin; Oxygen Consumption; Papaverine; Prenylamine; Pyridines; Triazoles; Vasodilator Agents; Verapamil | 1973 |
Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
Topics: Animals; Coronary Vessels; Coumarins; Dicarboxylic Acids; Dipyridamole; Dogs; Female; Femoral Artery; Femoral Vein; Glycolates; Khellin; Lidoflazine; Male; Nitrobenzenes; Nitroglycerin; Papaverine; Prenylamine; Pyridines; Pyrimidines; Renal Artery; Renal Veins; Vasodilator Agents; Verapamil | 1974 |
[Action of anti-arrhythmia agents on intracardiac conduction].
Topics: Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Benzofurans; Bundle of His; Cardiac Catheterization; Depression, Chemical; Diethylamines; Dogs; Electrocardiography; Heart Conduction System; Indans; Iodobenzoates; Lidocaine; Lidoflazine; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1974 |
[Therapy of angina pectoris. 3. Papaverine, xanthine and other drugs].
Topics: Angina Pectoris; Dipyridamole; Humans; Iproniazid; Khellin; Lidoflazine; Papaverine; Prenylamine; Verapamil; Xanthines | 1974 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; Nifedipine; Nitrates; Nitroglycerin; Perhexiline; Prenylamine; Tachycardia; Verapamil | 1983 |
Enhancement of cardioplegic myocardial protection with calcium entry blockers.
Topics: Calcium Channel Blockers; Diltiazem; Heart Arrest, Induced; Humans; Lidoflazine; Myocardium; Nifedipine; Organ Preservation; Verapamil | 1984 |
Calcium blockers in cerebral resuscitation.
Topics: Animals; Calcium Channel Blockers; Cardiopulmonary Bypass; Cerebral Cortex; Cerebrovascular Circulation; Dexamethasone; Dogs; Heart Arrest, Induced; Hypoxia, Brain; Intracranial Pressure; Lidoflazine; Magnesium Sulfate; Monitoring, Physiologic; Time Factors; Verapamil | 1983 |
Calcium entry blockers and vascular smooth muscle heterogeneity.
Topics: Animals; Calcium; Calcium Channel Blockers; Cinnarizine; Flunarizine; Gallopamil; Lidoflazine; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Verapamil | 1981 |
Clinical use of calcium entry blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Cinnarizine; Coronary Circulation; Coronary Vasospasm; Diltiazem; Flunarizine; Heart Rate; Humans; Lidoflazine; Nifedipine; Perhexiline; Verapamil | 1981 |